These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20187095)

  • 1. Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor).
    de Camargo VP; Keohan ML; D'Adamo DR; Antonescu CR; Brennan MF; Singer S; Ahn LS; Maki RG
    Cancer; 2010 May; 116(9):2258-65. PubMed ID: 20187095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG).
    Kasper B; Gruenwald V; Reichardt P; Bauer S; Rauch G; Limprecht R; Sommer M; Dimitrakopoulou-Strauss A; Pilz L; Haller F; Hohenberger P
    Eur J Cancer; 2017 May; 76():60-67. PubMed ID: 28282612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG).
    Garbay D; Le Cesne A; Penel N; Chevreau C; Marec-Berard P; Blay JY; Debled M; Isambert N; Thyss A; Bompas E; Collard O; Salas S; Coindre JM; Bui B; Italiano A
    Ann Oncol; 2012 Jan; 23(1):182-186. PubMed ID: 21444357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).
    Kummar S; O'Sullivan Coyne G; Do KT; Turkbey B; Meltzer PS; Polley E; Choyke PL; Meehan R; Vilimas R; Horneffer Y; Juwara L; Lih A; Choudhary A; Mitchell SA; Helman LJ; Doroshow JH; Chen AP
    J Clin Oncol; 2017 May; 35(14):1561-1569. PubMed ID: 28350521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoid fibromatosis: MRI features of response to systemic therapy.
    Sheth PJ; Del Moral S; Wilky BA; Trent JC; Cohen J; Rosenberg AE; Temple HT; Subhawong TK
    Skeletal Radiol; 2016 Oct; 45(10):1365-73. PubMed ID: 27502790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of Sorafenib against desmoid tumor/deep fibromatosis.
    Gounder MM; Lefkowitz RA; Keohan ML; D'Adamo DR; Hameed M; Antonescu CR; Singer S; Stout K; Ahn L; Maki RG
    Clin Cancer Res; 2011 Jun; 17(12):4082-90. PubMed ID: 21447727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROMIS Function Scores Are Lower in Patients Who Underwent More Aggressive Local Treatment for Desmoid Tumors.
    Newman ET; Lans J; Kim J; Ferrone M; Ready J; Schwab J; Raskin K; Calderon SL
    Clin Orthop Relat Res; 2020 Mar; 478(3):563-577. PubMed ID: 31429829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of extraabdominal desmoid tumors to therapy with imatinib mesylate.
    Mace J; Sybil Biermann J; Sondak V; McGinn C; Hayes C; Thomas D; Baker L
    Cancer; 2002 Dec; 95(11):2373-9. PubMed ID: 12436445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy in adult desmoid tumors.
    Patel SR; Evans HL; Benjamin RS
    Cancer; 1993 Dec; 72(11):3244-7. PubMed ID: 8242548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
    Toulmonde M; Pulido M; Ray-Coquard I; Andre T; Isambert N; Chevreau C; Penel N; Bompas E; Saada E; Bertucci F; Lebbe C; Le Cesne A; Soulie P; Piperno-Neumann S; Sweet S; Cecchi F; Hembrough T; Bellera C; Kind M; Crombe A; Lucchesi C; Le Loarer F; Blay JY; Italiano A
    Lancet Oncol; 2019 Sep; 20(9):1263-1272. PubMed ID: 31331699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution.
    Zheng C; Zhou Y; Wang Y; Luo Y; Tu C; Min L
    Drug Des Devel Ther; 2020; 14():3941-3950. PubMed ID: 33061299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmoid-type fibromatosis-associated Gardner fibromas: prevalence and impact on local recurrence.
    Cates JM; Stricker TP; Sturgeon D; Coffin CM
    Cancer Lett; 2014 Oct; 353(2):176-81. PubMed ID: 25064609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between tumor growth and hormonal therapy with MR signal characteristics of desmoid-type fibromatosis: A preliminary study.
    Gondim Teixeira PA; Chanson A; Verhaeghe JL; Lecocq S; Louis M; Hossu G; Blum A
    Diagn Interv Imaging; 2019 Jan; 100(1):47-55. PubMed ID: 30037746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral vinorelbine in young patients with desmoid-type fibromatosis.
    Kornreich L; Orbach D; Nicolas N; Brisse HJ; Berlanga P; Defachelles AS; Mansuy L; Verite C; Saumet L; Karanian M; Corradini N
    Tumori; 2023 Oct; 109(5):511-518. PubMed ID: 37114926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosis.
    Zanchetta E; Ciniselli CM; Bardelli A; Colombo C; Stacchiotti S; Baldi GG; Provenzano S; Bertulli R; Bini F; Casale A; Greco FG; Ferrari A; Verderio P; Fiore M; Gronchi A; Casali PG; Morosi C; Palassini E
    Cancer Med; 2021 Jul; 10(13):4356-4365. PubMed ID: 34102009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis.
    Fiore M; Colombo C; Radaelli S; Callegaro D; Palassini E; Barisella M; Morosi C; Baldi GG; Stacchiotti S; Casali PG; Gronchi A
    Eur J Cancer; 2015 Dec; 51(18):2800-7. PubMed ID: 26602014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Certain risk factors for patients with desmoid tumors warrant reconsideration of local therapy strategies.
    Bishop AJ; Landry JP; Roland CL; Ratan R; Feig BW; Moon BS; Zarzour MA; Wang WL; Lazar AJ; Lewis VO; Torres KE; Guadagnolo BA
    Cancer; 2020 Jul; 126(14):3265-3273. PubMed ID: 32343846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of apatinib for patients with advanced extremity desmoid fibromatosis: a retrospective study.
    Zheng C; Fang J; Wang Y; Zhou Y; Tu C; Min L
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2127-2135. PubMed ID: 33452581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable clinical efficacy of cytotoxic chemotherapy in patients with progressive desmoid tumors: a retrospective real-world study.
    Oh CR; Jeong H; Kim W; Lee JS; Song SY; Song JS; Cho KJ; Chung HW; Lee MH; Hong JY; Lee J; Kim JE; Ahn JH
    Int J Clin Oncol; 2024 Jun; 29(6):853-861. PubMed ID: 38526622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.
    Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA
    Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.